Autism Spectrum Disorder Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- The child must be between 4 and 10 years old
- The child must have been diagnosed with Autism Spectrum Disorder (ASD) using specific recognised diagnostic tools (DSM-5 criteria, confirmed by specialist assessments called ADOS and/or ADI-R)
- The child must have an IQ score of 50 or above, as measured by a standardised test
- A parent or guardian must have signed a consent form agreeing to participation
Who may not be able to join:
- Children who have any metal implants inside their body
- Children who have a neurological condition such as epilepsy
- Children whose brain MRI scan shows a structural problem that requires surgery
- Children who have been diagnosed with a genetic or chromosomal condition (confirm with trial site)
- Children who have been diagnosed with a mental health condition such as early-onset schizophrenia
- Children who have a serious heart condition
- Children who have increased pressure inside the skull (confirm with trial site)
- Children who are already taking part in another clinical trial
- Children who have started a new treatment or intervention programme within the 4 weeks before joining this trial
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Completion of the tTIS intervention protocol; Number of participants with adverse events
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.